Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.12 USD | -0.47% | -1.85% | -31.61% |
May. 09 | PMV Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 12 | Jefferies Starts PMV Pharmaceuticals With Buy Rating, $5 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.61% | 109M | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+45.38% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- PMVP Stock
- News PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals : Goldman Sachs Upgrades PMV Pharmaceuticals to Buy From Neutral, Lifts Price Target to $43 From $35